News
A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...
Regeneron’s shares have declined nearly 17% following the failure of the company’s Dupixent follow-up itepekimab.
New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist in advanced st ...
Regeneron isn’t the only Big Pharma to spot potential in Hansoh’s obesity pipeline. Merck & Co. ended last year paying $112 ...
TUCSON, AZ / ACCESS Newswire / June 2, 2025 / Umbrella Labs, a leading supplier of advanced research chemicals, announced the expansion of its peptide catalog to include Retatrutide (LY3437943), an ...
Drug-induced liver injury cases are increasing, with common medications and supplements posing hidden dangers, especially for ...
Verywell Health on MSN3h
6 Common Supplements That Could Be Harming Your LiverTurmeric is a popular dietary supplement for managing arthritis, digestive problems, and liver disease. However, some ...
The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback